ABSTRACT. To assess oxidant stress responses in newborn infants treated with elevated concentrations of oxygen, we measured plasma concentrations of glutathione (GSH) and glutathione disulfide (GSSG) in newborn infants ranging from 23 to 42 wk gestational age. All infants recruited into the study were mechanically ventilated and had catheters placed in their umbilical arteries a s part of their normal clinical management. Blood samples were obtained on d 1,3, and 5 and weekly thereafter or until the catheters were removed. W e observed plasma concentrations of GSSG in these infants that were frequently an order of magnitude higher than the 0.1 to 0.3 pM we find in adults. Interestingly, plasma GSSG concentrations were inversely correlated to the inspired oxygen tensions. This effect appeared to arise from the patient selection criteria whereby, of the infants studied, those breathing the lowest partial pressures of oxygen were the smallest and gestationally youngest. A second observation was that plasma concentrations of G S H in the premature infants were substantially, indeed often dramatically, lower than we have observed in adult humans (6 to 10 pM). Finally, we found that in patients with both umbilical arterial and umbilical venous catheters arterial GSSG concentrations were consistently higher than venous concentrations; conversely, arterial GSI4 concentrations were lower than venous concentrations. The elevated GSSG concentrations we observed in these infants indicate marked oxidant stress responses in prematurely born infants, even in those infants exposed only to room air. The positive arteriovenous gradients of GSSG concentrations across the lungs of these infants suggest that a t least some of the increased plasma GSSG originates in the lung. The low plasma G S H concentrations we observed in these same infants suggest deficiencies in an antioxidant that has been shown in numerous animal studies to be critical for prevention of hyperoxia-induced lung injury. Finally, the negative arteriovenous gradients of G S H concentrations across the lung provide the first evidence in humans for pulmonary uptake of GSH. (Pediatr Res 34: 360-365,1993) Abbreviations Fi02, fraction inspired oxygen GGT, y-glutamyltranspeptidase GSH, glutathione GSSG, glutathione disulfide PAO~, alveolar oxygen tension Pao2, arterial oxygen tension
ABSTRACT. To assess oxidant stress responses in newborn infants treated with elevated concentrations of oxygen, we measured plasma concentrations of glutathione (GSH) and glutathione disulfide (GSSG) in newborn infants ranging from 23 to 42 wk gestational age. All infants recruited into the study were mechanically ventilated and had catheters placed in their umbilical arteries a s part of their normal clinical management. Blood samples were obtained on d 1,3, and 5 and weekly thereafter or until the catheters were removed. W e observed plasma concentrations of GSSG in these infants that were frequently an order of magnitude higher than the 0.1 to 0.3 pM we find in adults. Interestingly, plasma GSSG concentrations were inversely correlated to the inspired oxygen tensions. This effect appeared to arise from the patient selection criteria whereby, of the infants studied, those breathing the lowest partial pressures of oxygen were the smallest and gestationally youngest. A second observation was that plasma concentrations of G S H in the premature infants were substantially, indeed often dramatically, lower than we have observed in adult humans (6 to 10 pM). Finally, we found that in patients with both umbilical arterial and umbilical venous catheters arterial GSSG concentrations were consistently higher than venous concentrations; conversely, arterial GSI4 concentrations were lower than venous concentrations. The elevated GSSG concentrations we observed in these infants indicate marked oxidant stress responses in prematurely born infants, even in those infants exposed only to room air. The positive arteriovenous gradients of GSSG concentrations across the lungs of these infants suggest that a t least some of the increased plasma GSSG originates in the lung. The low plasma G S H concentrations we observed in these same infants suggest deficiencies in an antioxidant that has been shown in numerous animal studies to be critical for prevention of hyperoxia-induced lung injury. Finally, the negative arteriovenous gradients of G S H concentrations across the lung provide the first evidence in humans for pulmonary uptake of GSH. The use of oxygen in the treatment of the newborn infant with respiratory insufficiency has both benefits and risks. Although often necessary to sustain life, increased concentrations of oxygen are toxic to cells and therapy with oxygen may play a role in the pathogenesis of chronic lung disease. Currently, n o useful marker is available for the assessment of the magnitude of the oxidant stress imposed by hyperoxic therapy.
In recent years, the measurement of GSSG has been used in vitro and in vivo in experimental animals as a method of quantifying oxidant stress (1-5). In biologic systems, GSSG is formed largely through the enzymatic reduction of hydroperoxides by GSH. Under normal circumstances, most GSSG formed intracellularly is reduced back to GSH by glutathione reductase at the expense of NADPH oxidation, but many cells export GSSG to extracellular fluids such as plasma, lymph, or, in the case of the liver, bile (5) .
Lambs and rats exposed to elevated oxygen concentrations have increased concentrations of GSSG in lung tissue (4, 6, 7) . In addition, administration of the redox-cycling lung toxin paraquat to rats has been shown to increase concentrations of GSSG in lung tissue and in blood plasma, particularly in arterial plasma ( I ) . Therefore, the present studies were designed to determine whether GSSG is measurable in arterial plasma of newborn infants and to test the hypothesis that in newborn infants exposure to increased concentrations of oxygen, as part of their normal clinical management, would result in increased plasma concentrations of GSSG. The answers to both questions are important to clinicians because the ability to monitor oxidant stress responses in patient populations would be helpful in adjusting therapy and could offer clues about the mechanisms of adverse effects of hyperoxia exposure (8) .
MATERIALS AND METHODS
Patiet~t population. The patient population consisted of term and preterm infants admitted to the neonatal intensive care unit at Texas Children's Hospital between 1988 and 1990. After obtaining informed consent from the parents, we enrolled infants that met the entry criteria for the study. All infants were receiving mechanical ventilation and had umbilical artery catheters with their tips at the level of the third lumbar interspace (many of these patients also had umbilical venous catheters in place with their tips in the right atrium). The protocol was approved by the institutional review boards of Baylor College of Medicine and Texas Children's Hospital.
Clinical data. In addition to biochemical measurements, we maintained a data base of clinical data including birth weight, gestational age of birth, and admitting diagnoses. We recorded Paoz and all data regarding ventilator settings including FiOz and calculated PAO?. Blood samples were not drawn specifically for the measurement of arterial blood gas tensions at the time of sampling for the measurements of GSH and GSSG. Duta ar1u1~:sis. We prospectively divided the infants enrolled in the study into three groups, according to birth wt and oxygen requirement. Group I consisted of preterm infants of birth wt less than 1.5 kg who were intubated in the delivery room and ventilated in the first week of life to prevent apnea. These infants did not have lung disease and were usually ventilated with room air. No infant was included in this group if more than 40% oxygen was required. This group was considered at low risk for oxygen-induced lung injury and constituted the control population for exposure to hyperoxia.
Group 2 consisted of infants of all birth weights who were mechanically ventilated with elevated concentrations of oxygen for respiratory insufliciency secondary to parenchymal lung disease. This group consisted primarily of preterm infants with hyaline membrane disease and of developmentally more mature infants with parenchymal lung diseases, such as meconium aspiration pneumonia, bacterial pneumonia, or congenital heart disease and pulmonary edema. These infants were generally ventilated with h i~h concentrations of oxvgen and were consid--. -ered at risk for development of oxygen-induced lung injury.
Group 3 consisted of near-term infants who were mechanically ventilated for respiratory failure without parenchymal lung disease. These infants all had idiopathic persistent pulmonary hypertension of the newborn and were intensely cyanotic despite having relatively normal chest x-rays and lung mechanics. They were a n important control group because, in contrast to the infants in group 2, they had no detectable parenchymal disease initially but were ventilated with nearly 100% oxygen for 3 to 7 d. S!atistical anal~~se.~. We compared data among groups of patients using a one-way analysis of variance followed by a Newman-Keuls multiple comparison test, with significance at p < 0.05. Arteriovenous differences in GSH and GSSG concentrations were evaluated by paired t tests. In addition, plasma concentrations of GSH and GSSG were compared with other variables by linear regression analyses (9).
Patictlt poplrlation. As expected, the infants in groups 1 and 2
were smaller and less mature than those in group 3 (Table 1) . Infants in group 1 also required the least amount of supplemental oxygcn (less than half that of group 2 or 3) and had the lowest alveolar oxygen tensions (Table 2) . Arterial oxygen tensions were not different among the three groups. P1usi)zu GSSG conccr~frutions. Plasma GSSG concentrations were 30% greater in group 1 infants compared with group 2 infants and almost twice those of group 3 infants. Least squares linear regression analysis of plasma GSSG concentrations vcrs1r.s F i 0 2 gave a line with a slope that was different from 0 ( p C 0.003) (Fig. 1) . Unexpectedly, the slope of this line was -0.36 pM GSSGIatmosphere oxygen, suggesting that plasma GSSG concentrations were inversely related to FiOz. However, almost all infants in the low FiOz group were members of group 1 and therefore were very immature. Thus, we performed a linear regression analysis of GSSG concentrations against gestational age. This analysis (Fig. 2 ) also gave a line with a slope that was different from 0, p < 0.03 (slope = -0.016 pM GSSGIwk gestation). The somewhat weaker (and negative) association of arterial plasma GSSG with gestational age indicated by linear regression analysis might be influenced by the restrictive and unnecessary assumption that a possible relationship be linear. Therefore, we compared plasma GSSG concentrations in infants born at less than 34 wk of gestational age with those born at 34 wk or more (Table 3) . We found that arterial plasma GSSG concentrations were higher in the young infants ( p < 0.008) than in the older infants (unpaired t test), despite the significantly lower FiOz and P A O~ values recorded for the younger infants.
We also obtained 66 simultaneous measurements of GSSG concentrations in arterial and venous plasma (Table 4) . Arterial GSSG concentrations were roughly 25% higher than in the corresponding venous samples. By paired t test, this difference was significant for the group as a whole ( p < 0.01) and for the subset of infants between 23 and 33 wk gestation ( p < 0.03).
Plusnza GSII corzccrzfru!iotzs. There were no significant differences in GSH concentrations among the three groups of infants (Table 2 ). Least squares linear regression analysis of GSH as a function of gestational age, however, gave a line with a slope of 0.06 pM GSH/wk gestation (Fig. 3 ) that was different from 0 ( p < 0.004). Furthermore, when infants less than 34 wk were compared with those more than 34 wk (Table 3) , arterial plasma GSH concentrations were higher in the older infants ( p < 0.006).
Simultaneous measurements of arterial and venous plasma GSH concentrations revealed that the arterial GSH concentrations were roughly 10% less than the corresponding venous concentrations. By paired t test, this difference was statistically significant for the group as a whole ( p < 0.02) and for the group between 23 and 33 wk gestation ( p < 0.02).
P/asr?za GSHIGSSG rulio. Because plasma GSH concentra- Gestational Age in Weeks If observed in properly matched groups of cxperimental animals, the differences in GSSG concentrations that we observed between these infants and normal adults would be interpreted as evidence of marked oxidant stress in the experimental group. However, comparisons of the infants with healthy adults are not as readily interpretable. The data d o suggest that these infants may not be able to deal adequately with the oxidant stresses they are encountering. Elevated plasma GSSG concentrations could result if the infants were exposed to oxidant stresses that were excessive compared with normal adults, if infants' antioxidant enzyme activities were compromised, or some combination of both. Interestingly, the plasma GSSG concentrations we obsenned in the prematurely born infants also are more than the GSSG concentrations observed by Buhl 01 al. (10) in HIV-infected adults or by us in infected children ( I I), despite the extensive evidence implicating the involvement of oxidant stress mechanisms in the progression of HIV infection (14) .
In infants with both arterial and venous cathetcrs, we found that GSSG concentrations in arterial plasma were significantly greater than simultaneously determined GSSG concentrations in vcnous plasma (Table 4 ). This suggests a measurable net release ofGSSG by the lungs. Similar arteriovcnous difircnccs in GSSG conccntrations across the lungs have bccn reported for rats treated with the redox-cycling lung toxin, paraquat (I). Not all individual GSSG differences were negative, probably reflecting relatively small effects of the lungs on plasma GSSG, often close to the limitations of the precision of our analytical methods. In addition, GSSG has been shown to support GSH synthesis in isolated rat lungs. albeit lcss efliciently than with GSH (15) , and in individual patients it is possible that GSSG released from other organs could have been undergoing net uptake by the lungs.
The clinical and physiologic implications of the GSSG conccntrations observed in these infants arc not clear. Presently, we arc unaware of any evidence that elevated plasma concentrations of GSSG mediate any adverse responses. Thiol-disulfide exchange with protein thiols by GSSG can modulate the activities ofccrtain enzymes (16), but the physiologic or toxicologic clTccts of GSSG arc lcss certain than are the implications that increased rates of efllux of GSSG reflect incrcased exposure to oxidants such as hydrogen peroxide, compromise of cellular glutathione reductase activities, or both.
/'/(~.stila G S f l twnc.c~tltrotiot1.v. The plasma concentrations of GSH in the infants in the present study are lower than the 6 to 10 pM conccntrations we typically observe in plasma from healthy adult humans. Although the comparison of the GSH conccntrations in these infants with the corresponding values in healthy adults is subject to the same limitations previously discussed for GSSG, the comparison does offer a useful perspective to view the data on the infants. In the infants we studied. there was a tendency for the older infants to exhibit higher plasma GSH concentrations, and a linear regression analysis of the data shows a statistically significant ( p < 0.036) correlation between GSH and gestational age at birth (Fig. 3) . As with plasma GSSG, considerable scatter is seen in the GSH concentrations, but also as with GSSG, these plasma GSH concentrations are distinctly different from the concentrations we typically observe in healthy adults. In fact, the plasma GSH concentrations observed in the infants are comparable to the GSH concentrations found in HIV-infected adults and children (10. 11).
The importance of GSH in normal functioning of cellular defense mechanisms is well recognized, and depletion of GSlI by fasting, restricting dietary sources of divalent sulfur or treatment with L-buthionine-[S.R]-sulfoximine has been reported to enhance the sensitivity of experimental animals to the adverse effects of hyperoxia (17) (18) (19) (20) and other potentially damaging challenges such as has been characterized for toxic doses of acetaminophen (31). In addition to the stresses created by increased oxidation of GSH to GSSG. the hyperoxia-stimulated peroxidation of endogenous lipids and subsequent reactions produce several electrophilic products, such as 4-hydroxy-2-nonenal that can irreversibly consume GSH via Michael addition rcactions and exert cytotoxic effects if GSH availability is insufficient for adequate cellular defense functions (22) .
GSH concentrations of lung tissue and extracellular fluids (plasma, alveolar lining fluid) decrease in experimental animals exposed to hyperoxia (7, (23) (24) , but the extents of depletion of GSH observed in these studies are moderate relative to the changes in GSH observed in the models of acute lethal injury such as acetaminophen poisoning, where more marked GSH depletion thresholds to toxicity are observed (21) . The moderate depletion of whole tissue GSH observed suggests that the critical targets for hyperoxic lung injury may lie in specific cell types or subcellular pools in which depletion is not evident through analysis of whole tissue, plasma, or epithelial lining fluids. The reports that long-term administration of L-buthionine-[S,R]-sulfoximine to mice (25) and newborn rats (26) causes adverse effects that in some ways mimic those of hyperoxic exposure lend further credibility to the hypothesis that localized depletion of GSH can be a significant determinant of hyperoxic injury. It follows that the inability to sustain suitable supplies of GSH can contribute significantly to the damaging effects of hyperoxia. Although the primary function of plasma GSH may be to serve as a cysteine supply for GSH and protein synthesis by extrahepatic tissues (1, 21), more recent studies report a dramatic stabilization of nitric oxide in a bioactive form by adduct formation with GSH (27) . The idea that plasma GSH status might appreciably affect the disposition and effects of nitric oxide produced by vascular endothelial cells is attractive but requires further investigation. The plasma GSH concentrations we observed in the premature infants suggest a relative deficiency wherein some form of supplementation might benefit some patients. The significantly greater concentrations of GSH in the plasma of the older infants ( Table 3 , Fig. 4 ) suggest developmental effects, but whether increased synthesis and emux or decreased clearance from the vascular compartment with increasing gestational age is responsible is not known.
Purucker and Wernze (28) have recently reported measurements of plasma GSH and GSSG in blood drawn from different vascular beds in 10 patients without liver dysfunction and concluded that substantial translocation of GSH from the liver to the plasma did not occur in humans. These investigators estimated plasma GSH concentrations to be uniformly around 1 pM. However, they did not indicate the use of inhibitors of y GGT in the workup of the blood samples they obtained, whereas we added the blood to equal volumes of ice-cold buffer containing 50 mM serine borate immediately on obtaining the blood. Serine borate inhibits GGT efficiently and quickly, and although we did not measure plasma or serum GGT activities in the infants in our study, GGT activities typically are higher in newborn infants (10 to 100 U/L) than in adults (up to 30 U/L) (29) . Purucker and Wernze did measure GGT activities in their subjects and found 14.9 f 2.6 U/L. This means that, on average, 1 L of their subjects' plasmas had enough GGT activity to degrade 14.9 ctmol of y-glutamyl-containing substrate in 1 min at 25"C, which is far in excess of the GSH concentrations we find even in adults. It appears that in their study about 10 min elapsed from drawing the blood to deactivation of GGT activity by addition of sulfosalicylic acid to denature plasma proteins. They report very high analytical recoveries of added GSH and GSSG, which may indicate that other factors, such as availability of acceptor substrate, could control GGT-mediated conversions in nonproportional ways. The GSH concentrations we determined with monobromobimane and reverse-phase HPLC are in good agreement with the concentrations we estimated with the enzyme recycling methods.
The relatively low GSH concentrations we observed in the infants couple with the relatively high concentrations of GSSG to result in GSH/GSSG ratios (Fig. 4) that are very low, relative to the ratios we find in adults (20-100). Insofar as this ratio offers a useful assessment of oxidant stress status (5), these infants are uniformly under an oxidant stress that decreases with gestational maturation.
In infants with both arterial and venous catheters, we found that GSH measurements in arterial plasma were significantly lower than simultaneous measurements in venous plasma (Table   4 ). The negative arteriovenous difference is consistent with a net uptake of GSH by the lungs. Again, not all individual GSH differences are negative, which could result from attempts to measure biologic differences that are close to the error of our analytical methods. However, net pulmonary release of GSH secondary to cell lysis could also account for a real net release of GSH to the circulation of some individuals.
Conchrsion. In summary, we found that plasma GSSG concentrations were elevated in preterm infants compared with adults and that this elevation was inversely correlated with gestational age. The positive gradient for GSSG across the lung suggests that at least some plasma GSSG is derived from lung tissue. This increase in GSSG could be the result of increased production of reactive oxygen species, deficient antioxidant activities, or some combination of both. Additionally, we found that plasma GSH concentrations were relatively low in preterm infants compared with normal adults and that GSH concentrations increased with increasing gestational age. Whether this apparent deficiency leaves these infants more susceptible to tissue injury by reactive oxygen remains to be determined. Finally, we found a negative gradient for GSH across the lung, suggesting lung uptake of GSH. To our knowledge, this is the first report of evidence for GSH uptake by the lung in humans.
